Clinical Trial Update: Intestinal Glucagon-like Peptide-1 (GLP-1) and the Physiological Role in Eating in Humans [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the physiological role of intestinal GLP-1 in eating behavior in humans has completed, sponsored by University Hospital Basel.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Appetite Disorders
• Nutritional Disorders

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Appetite and General Nutritional Disorders | Phase 1 | Status: COMPLETED